Organon & Co. (OGN) Short Interest Ratio & Short Volume → Americans Now Need $1.46M to Retire… (From Crypto 101 Media) (Ad) Free OGN Stock Alerts $21.52 -0.13 (-0.60%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Organon & Co. Short Interest DataCurrent Short Volume12,090,000 sharesPrevious Short Volume10,940,000 sharesChange Vs. Previous Month+10.51%Dollar Volume Sold Short$224.99 millionShort Interest Ratio / Days to Cover5.1Last Record DateApril 30, 2024Outstanding Shares257,171,000 sharesFloat Size256,660,000 sharesShort Percent of Float4.71%Today's Trading Volume1,825,981 sharesAverage Trading Volume2,674,329 sharesToday's Volume Vs. Average68% Short Selling Organon & Co. ? Sign up to receive the latest short interest report for Organon & Co. and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOGN Short Interest Over TimeOGN Days to Cover Over TimeOGN Percentage of Float Shorted Over Time Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Organon & Co. Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,090,000 shares $224.99 million +10.5%4.7%5.1 $18.61 4/15/202410,940,000 shares $193.75 million +0.1%4.3%4.7 $17.71 3/31/202410,930,000 shares $205.48 million +7.9%4.3%4 $18.80 3/15/202410,130,000 shares $185.18 million +4.3%4.0%3.4 $18.28 2/29/20249,710,000 shares $169.05 million -27.2%3.8%2.7 $17.41 2/15/202413,340,000 shares $248.39 million +8.2%5.2%3.4 $18.62 Get the Latest News and Ratings for OGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organon & Co. and its competitors with MarketBeat's FREE daily newsletter. 1/31/202412,330,000 shares $205.29 million -10.7%4.8%3 $16.65 1/15/202413,810,000 shares $231.32 million -27.8%5.4%3 $16.75 12/31/202319,120,000 shares $275.71 million +5.8%7.5%3.4 $14.42 12/15/202318,070,000 shares $236.36 million +25.8%7.1%3.3 $13.08 11/30/202314,370,000 shares $162.67 million -1.7%5.6%2.9 $11.32 11/15/202314,620,000 shares $169.01 million +36.3%5.7%3.2 $11.56 10/31/202310,730,000 shares $158.70 million -3.3%4.2%2.5 $14.79 10/15/202311,100,000 shares $192.25 million +10.9%4.4%3 $17.32 9/30/202310,010,000 shares $173.77 million +37.9%3.9%4.1 $17.36 9/15/20237,260,000 shares $141.86 million +4.3%2.8%3.3 $19.54 8/31/20236,960,000 shares $152.84 million -0.9%2.7%3.3 $21.96 8/15/20237,020,000 shares $163.29 million +12.9%2.8%3.3 $23.26 7/31/20236,220,000 shares $136.72 million -7.2%2.4%2.7 $21.98 7/15/20236,700,000 shares $137.48 million -8.3%2.6%3.2 $20.52 6/30/20237,310,000 shares $152.12 million +5.5%2.9%3.6 $20.81 6/15/20236,930,000 shares $144.94 million -4.4%2.7%3.5 $20.92 5/31/20237,250,000 shares $140.58 million +5.1%2.9%3.5 $19.39 5/15/20236,900,000 shares $143.80 million +11.7%2.7%3.3 $20.84 4/30/20236,180,000 shares $152.21 million -8.9%2.4%3 $24.63 4/15/20236,780,000 shares $161.36 million -1.2%2.7%3.4 $23.80 3/31/20236,860,000 shares $161.35 million +7.4%2.7%3.2 $23.52 3/15/20236,390,000 shares $137.51 million -12.2%2.5%3 $21.52 2/28/20237,280,000 shares $178.29 million +31.7%2.9%3.4 $24.49 2/15/20235,530,000 shares $161.81 million +15.9%2.2%2.7 $29.26 1/31/20234,770,000 shares $143.72 million -22.6%1.9%2.5 $30.13 1/15/20236,160,000 shares $197.49 million -14.2%2.4%3 $32.06 12/30/20227,180,000 shares $200.54 million +4.5%2.8%3.6 $27.93 12/15/20226,870,000 shares $194.28 million +16.4%2.7%3.4 $28.28 11/30/20225,900,000 shares $153.52 million +7.1%2.3%3 $26.02 11/15/20225,510,000 shares $137.09 million -3.0%2.2%2.9 $24.88 10/31/20225,680,000 shares $148.70 million -1.7%2.2%3 $26.18 10/15/20225,780,000 shares $134.73 million -4.3%2.3%3.2 $23.31 9/30/20226,040,000 shares $141.34 million +1.7%2.4%3.5 $23.40 9/15/20225,940,000 shares $170.78 million +12.3%2.3%3.8 $28.75Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. OGN Short Interest - Frequently Asked Questions What is Organon & Co.'s current short interest? Short interest is the volume of Organon & Co. shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 12,090,000 shares of OGN short. 4.71% of Organon & Co.'s shares are currently sold short. Learn More on Organon & Co.'s current short interest. What is a good short interest ratio for Organon & Co.? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OGN shares currently have a short interest ratio of 5.0. Learn More on Organon & Co.'s short interest ratio. Which institutional investors are shorting Organon & Co.? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Organon & Co.: Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, IMC Chicago LLC, and Nomura Holdings Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Organon & Co.? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.71% of Organon & Co.'s floating shares are currently sold short. Is Organon & Co.'s short interest increasing or decreasing? Organon & Co. saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 12,090,000 shares, an increase of 10.5% from the previous total of 10,940,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organon & Co.'s float size? Organon & Co. currently has issued a total of 257,171,000 shares. Some of Organon & Co.'s outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organon & Co. currently has a public float of 256,660,000 shares. How does Organon & Co.'s short interest compare to its competitors? 4.71% of Organon & Co.'s shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Organon & Co.: BridgeBio Pharma, Inc. (11.52%), Ionis Pharmaceuticals, Inc. (6.53%), Apellis Pharmaceuticals, Inc. (10.21%), Cytokinetics, Incorporated (13.51%), Blueprint Medicines Co. (7.42%), Madrigal Pharmaceuticals, Inc. (18.68%), Alpine Immune Sciences, Inc. (5.67%), Nuvalent, Inc. (20.08%), Alkermes plc (7.62%), Perrigo Company plc (2.54%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Organon & Co. stock? Short selling OGN is an investing strategy that aims to generate trading profit from Organon & Co. as its price is falling. OGN shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organon & Co.? A short squeeze for Organon & Co. occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OGN, which in turn drives the price of the stock up even further. How often is Organon & Co.'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BridgeBio Pharma Short Interest Ionis Pharmaceuticals Short Interest Apellis Pharmaceuticals Short Interest Cytokinetics Short Interest Blueprint Medicines Short Interest Madrigal Pharmaceuticals Short Interest Alpine Immune Sciences Short Interest Nuvalent Short Interest Alkermes Short Interest Perrigo Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:OGN) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe #1 Investment of the Decade… Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Nvidia WarningAltimetry